Advertisement

Topics

Feasibility Trial of rTMS for Cannabis Use Disorder

2018-06-03 22:30:15 | BioPortfolio

Published on BioPortfolio: 2018-06-03T22:30:15-0400

Clinical Trials [426 Associated Clinical Trials listed on BioPortfolio]

A Preliminary Investigation of Pre-Frontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Use Disorder

This investigation will preliminarily determine if a course of high frequency rTMS applied to the left dorsolateral prefrontal cortex, will reduce cue elicited craving, and cue reactivity ...

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia

The high prevalence of cannabis and other substance use disorders are a major barrier to recovery in people with schizophrenia. Moreover, schizophrenia patients have significant deficits i...

Excitatory rTMS to the Left Dorsolateral Pre-Frontal Cortex to Reduce Cannabis-Cue Induced Craving

This is a double-blind, crossover trial that will recruit a cohort of non-treatment seeking Cannabis use disordered participants. Participants will then undergo either active, or sham rTMS...

rTMS Treatment for Cannabis Use Disorders in Psychosis

Cannabis use during adolescence represents a significant risk factor for the development of psychosis including schizophrenia. Moreover, cannabis is the most commonly used drug among patie...

Nabilone in Cannabis Users With PTSD

Despite the prevalence of cannabis use among the PTSD population and self-reports that it is used to help cope with PTSD symptoms, the direct effects of cannabis on PTSD symptomology are u...

PubMed Articles [314 Associated PubMed Articles listed on BioPortfolio]

Testing the role of the posterior cingulate cortex in processing salient stimuli in cannabis users: an rTMS study.

The posterior cingulate cortex (PCC) and precuneus are hubs in the default mode network and play a role in processing external salient stimuli. Accordingly, activation in these regions has been associ...

Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol.

Research typically characterizes cannabis use by self-report of cannabis intake frequency. In an effort to better understand relationships between measures of cannabis use, we evaluated if Δ-9-tetrah...

Cannabis Use and Bleomycin: An Overview and Case Study of Pulmonary Toxicity.

Legalization efforts in many states have heightened awareness of the medicinal uses of cannabis, and oncology nurses are more frequently caring for patients who have used or are using cannabis. Signif...

Price Elasticity of Illegal vs Legal Cannabis: A Behavioral Economic Substitutability Analysis.

The evolving legal status of cannabis worldwide necessitates evidence-based regulatory policies to minimize risks associated with cannabis misuse. A prominent concern is the impact legalization may ha...

Meta-analysis of the Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression.

Repetitive transcranial magnetic stimulation (rTMS) is a new type of physiotherapy technology that has been widely used in the research of depression. Although many clinical trials have found that com...

Medical and Biotech [MESH] Definitions

Compound isolated from Cannabis sativa extract.

A physiologically inactive constituent of Cannabis sativa L.

Inhaling and exhaling the smoke from CANNABIS.

A plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. It is most notable for the members, Cannabis and Hops.

Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.

More From BioPortfolio on "Feasibility Trial of rTMS for Cannabis Use Disorder"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial